Literature DB >> 22569231

Multifunctionalized mesoporous silica nanoparticles for the in vitro treatment of retinoblastoma: Drug delivery, one and two-photon photodynamic therapy.

Magali Gary-Bobo1, Youssef Mir, Cédric Rouxel, David Brevet, Ouahiba Hocine, Marie Maynadier, Audrey Gallud, Afitz Da Silva, Olivier Mongin, Mireille Blanchard-Desce, Sébastien Richeter, Bernard Loock, Philippe Maillard, Alain Morère, Marcel Garcia, Laurence Raehm, Jean-Olivier Durand.   

Abstract

In this work, we focused on mesoporous silica nanoparticles (MSN) for one photon excitated photodynamic therapy (OPE-PDT) combined with drug delivery and carbohydrate targeting applied on retinoblastoma, a rare disease of childhood. We demonstrate that bitherapy (camptothecin delivery and photodynamic therapy) performed with MSN on retinoblastoma cancer cells was efficient in inducing cancer cell death. Alternatively MSN designed for two-photon excited photodynamic therapy (TPE-PDT) were also studied and irradiation at low fluence efficiently killed retinoblastoma cancer cells.
Copyright © 2012 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22569231     DOI: 10.1016/j.ijpharm.2012.04.056

Source DB:  PubMed          Journal:  Int J Pharm        ISSN: 0378-5173            Impact factor:   5.875


  10 in total

Review 1.  Development of mesoporous silica-based nanoparticles with controlled release capability for cancer therapy.

Authors:  Harutaka Mekaru; Jie Lu; Fuyuhiko Tamanoi
Journal:  Adv Drug Deliv Rev       Date:  2015-10-03       Impact factor: 15.470

2.  Emerging applications of porphyrins in photomedicine.

Authors:  Haoyuan Huang; Wentao Song; James Rieffel; Jonathan F Lovell
Journal:  Front Phys       Date:  2015-04-10

Review 3.  Luminescent silica nanoparticles for cancer diagnosis.

Authors:  W Arap; R Pasqualini; M Montalti; L Petrizza; L Prodi; E Rampazzo; N Zaccheroni; S Marchiò
Journal:  Curr Med Chem       Date:  2013       Impact factor: 4.530

4.  Involvement of lysosomal exocytosis in the excretion of mesoporous silica nanoparticles and enhancement of the drug delivery effect by exocytosis inhibition.

Authors:  Rolando E Yanes; Derrick Tarn; Angela A Hwang; Daniel P Ferris; Sean P Sherman; Courtney R Thomas; Jie Lu; April D Pyle; Jeffrey I Zink; Fuyuhiko Tamanoi
Journal:  Small       Date:  2012-11-14       Impact factor: 13.281

Review 5.  Shining light on nanotechnology to help repair and regeneration.

Authors:  Asheesh Gupta; Pinar Avci; Magesh Sadasivam; Rakkiyappan Chandran; Nivaldo Parizotto; Daniela Vecchio; Wanessa C M A de Melo; Tianhong Dai; Long Y Chiang; Michael R Hamblin
Journal:  Biotechnol Adv       Date:  2012-08-21       Impact factor: 14.227

Review 6.  Exploring the role of mesoporous silica nanoparticle in the development of novel drug delivery systems.

Authors:  Senitta Stephen; Bapi Gorain; Hira Choudhury; Bappaditya Chatterjee
Journal:  Drug Deliv Transl Res       Date:  2021-02-18       Impact factor: 4.617

7.  Remotely Triggered Nano-Theranostics For Cancer Applications.

Authors:  Alexandra Sneider; Derek VanDyke; Shailee Paliwal; Prakash Rai
Journal:  Nanotheranostics       Date:  2017

8.  Delivery of cancer therapeutics using nanotechnology.

Authors:  Eun-Kyung Lim; Eunji Jang; Kwangyeol Lee; Seungjoo Haam; Yong-Min Huh
Journal:  Pharmaceutics       Date:  2013-05-15       Impact factor: 6.321

Review 9.  Mesoporous silica nanoparticles for drug and gene delivery.

Authors:  Yixian Zhou; Guilan Quan; Qiaoli Wu; Xiaoxu Zhang; Boyi Niu; Biyuan Wu; Ying Huang; Xin Pan; Chuanbin Wu
Journal:  Acta Pharm Sin B       Date:  2018-02-12       Impact factor: 11.413

Review 10.  Ligand-Targeted Delivery of Photosensitizers for Cancer Treatment.

Authors:  Piotr Gierlich; Ana I Mata; Claire Donohoe; Rui M M Brito; Mathias O Senge; Lígia C Gomes-da-Silva
Journal:  Molecules       Date:  2020-11-14       Impact factor: 4.411

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.